DUCTAL CARCINOMA IN SITU
Clinical trials for DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a drug shrink Pre-Cancerous breast cells before surgery?
Disease control CompletedThis study tested the drug ruxolitinib in 84 people with high-risk breast conditions like DCIS or atypical hyperplasia. Half took ruxolitinib for about 15 days before surgery, and the other half took a placebo. The goal was to see if ruxolitinib could increase cell death in abnor…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Julie Nangia • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New camera spots hidden cancer nodes during surgery
Diagnosis CompletedThis study tested a new handheld gamma camera (CarolIReS) to help surgeons find and remove sentinel lymph nodes in 110 women with early breast cancer or ductal carcinoma in situ. The camera was used before and during surgery to spot nodes that other methods might miss. The goal w…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated May 22, 2026 14:04 UTC
-
Rare male breast cancer cases examined in small study
Knowledge-focused CompletedThis study looked at the medical records of 8 men diagnosed with breast cancer at Methodist Health System. The goal was to learn more about their backgrounds, how the disease progressed, and what happened after treatment. The information gathered helps doctors better understand t…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC